Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(7); doi: 10.25236/FMSR.2022.040702.

A Personalized Nursing Care of DSA Complicated with Contrast Media Encephalopathy

Author(s)

Yuna Cai, Jie Yao, Xixi Huang, Jingjing Cao, Xiaowei Li

Corresponding Author:
Jie Yao
Affiliation(s)

Department of Integrated Traditional Chinese and Western Medicine Orthopedic Care, Shaanxi University of Chinese Medicine, 712000, Xianyang, Shaanxi, China

Abstract

This article reports a case of DSA examination of the head using a contrast agent. Neurological symptoms appear at the end of the examination. After excluding other diseases, it is considered as contrast agent encephalopathy. After the symptoms appear, after active rescue, after the patient's condition is stable, the clinical symptoms of the patient are combined with the characteristic treatment of traditional Chinese medicine to do a good job of nursing work to relieve the patient's symptoms and promote their recovery. This article is based on the treatment of western medicine, combined with the characteristic therapies of traditional Chinese medicine, and provides a new way of thinking for personalized nursing of contrast encephalopathy by combining Chinese and Western medicine.

Keywords

Contrast-medium encephalopathy; Cranial DSA; Nursing

Cite This Paper

Yuna Cai, Jie Yao, Xixi Huang, Jingjing Cao, Xiaowei Li. A Personalized Nursing Care of DSA Complicated with Contrast Media Encephalopathy. Frontiers in Medical Science Research (2022) Vol. 4, Issue 7: 7-11. https://doi.org/10.25236/FMSR.2022.040702.

References

[1] Yao Ying, Sun Yi, Liu Qun, Sui Yan. A case report of contrast medium encephalopathy after coronary intervention in maintenance hemodialysis patients[J]. Chinese Journal of Practical Internal Medicine, 2020, 40(12): 1046- 1048.

[2] Yao Meiyu, Zhang Hong. A case report of contrast-medium encephalopathy and literature review[J]. Stroke and Neurological Diseases, 2019, 02:241-242

[3] Cheng Si, Qiu Ming, Han Jianguo, Wu Chong, Su Li, Du Shiwei. Three cases of contrast-induced encephalopathy were reported [A]. Chinese Medical Doctor Association, Chinese Medical Doctor Association Neurosurgeon Branch. The 15th Chinese Physician Abstract Collection of Association Neurosurgeons Annual Meeting[C]. Chinese Medical Doctor Association, Chinese Medical Doctor Association Neurosurgeon Branch: Chinese Medical Doctor Association Neurosurgeon Branch, 2020: 3.

[4] Wang Xiaoyan, Zhao Changlin, Xia Liping, Jia Yuqin. A report of 2 cases of contrast-medium encephalopathy[J]. Journal of Clinical Neurology, 2020, 33(04): 295+304.

[5] Yang Ruilin, Wu Yaowen, Xin Jingli, Hu Hao. A preliminary study on the application of electronic biofeedback therapy combined with music therapy in patients with chronic schizophrenia[J]. Liaoning Medical Journal, 2020, 34(05): 49-51.

[6] Chen Liji. Application of air pressure therapy in the prevention of DVT after gynecological tumor surgery[J]. Chinese Health Standard Management, 2020, 11(21): 142-144.

[7] National Health Commission. 2018 China Health Statistics Summary [M]. Beijing: Peking Union Medical College Press, 2018: 1.

[8] Chinese Medical Association Neurology Branch, Chinese Medical Association Neurology Branch Neurovascular Intervention Cooperative Group. Chinese Expert Consensus on Cerebral Angiography Operation Specifications [J]. Chinese Journal of Neurology, 2018, 51(1): 7-13 .

[9] Leong S, Fanning NF. Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. A case report and review of the literature. Interv Neuroradiol. 2012;18(1):33-41.

[10] Kocabay G, Karabay CY, Kalayci A, et al. Contrast-induced neurotoxicity after coronary angiography. Herz. 2014;39(4):522-527. 

[11] Fischer-Williams M, Gottschalk PG, Browell JN. Transient cortical blindness. An unusual complication of coronary angiography. Neurology. 1970;20(4):353-355.

[12] Gollol Raju NS, Joshi D, Daggubati R, Movahed A. Contrast induced neurotoxicity following coronary angiogram with Iohexol in an end stage renal disease patient. World J Clin Cases. 2015;3(11):942-945. 

[13] Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Ann Neurol. 1983;13(5):469-484. 

[14] Rapoport S, Bookstein JJ, Higgins CB, Carey PH, Sovak M, Lasser EC. Experience with metrizamide in patients with previous severe anaphylactoid reactions to ionic contrast agents. Radiology. 1982;143(2):321-325. 

[15] Yu J, Dangas G. Commentary: New insights into the risk factors of contrast-induced encephalopathy. J Endovasc Ther. 2011;18(4):545-546.

[16] Yue Xuanye, Li Ziran, Xi Gangming. Three cases of acute mental disorder caused by iohexol[J]. Chinese Journal of Psychiatry, 2007, 40(1): 14.

[17] Li Feiou, Zhang Jianjun, Liu Wenting, Ma Guiling, Li Yanbing, Li Qiang, Tong Zichuan, Wei Yu. Characteristics of contrast encephalopathy after coronary intervention[J]. Journal of Clinical Cardiovascular Diseases, 2017, 33(6): 518-521.